Until now, PEDF function has been examined in a wide range of cancers, including osteosarcoma, prostate cancer, breast cancer, and hepatocellular carcinoma (19, 20, 43, 49–51). This evidence concerns the gene SERPINF1 and Familial prostate cancer.